Navigation Links
Roche confirms Tamiflu production talks in US

Swiss pharmaceutical giant Roche confirmed that it is in talks with 15 companies in the U.S. about stepping up the production of Tamiflu, the bird-flu drug//.

The partnership would dramatically increase the world's supply of Tamiflu as countries are stockpiling the drug in preparation for a possible bird flu pandemic.

The Basel-based firm confirmed on Thursday that it was in talks with Teva Pharmaceuticals and Mylan Laboratories, but declined to provide the names of any other companies.

"Roche is in advanced discussions with potential partners that can help enhance its supply chain and add capacity for certain specialized steps in the manufacturing of Tamiflu," the company said in a statement.

It added that it was "moving ahead as planned with third-party discussions" and would publish further details at a later date.

Increasing supply

The statement came after US Senator Charles Schumer said, "the purpose is not to break the patent on Tamiflu, but rather to meet an emergency need for quantities of this drug that Roche itself simply cannot do alone."

"Roche has made the right decision," Schumer said. "Instead of closely holding their patent rights and production techniques, in the face of a global health risk, they've moved swiftly to partner with multiple companies to dramatically increase production of this potentially life-saving drug."

The drug is in short supply in many parts of the world because of the fear of bird flu, a form of influenza that has been contracted by humans who have had close contact with infected poultry.

Tamiflu is one of four drugs known to work against influenza. It does not cure the virus but can reduce the severity of infection. Doctors believe it may help control a pandemic of H5N1 avian influenza, although evidence suggests it may be less effective than it is against seasonal influenza.

The drug, invented by California-based Gilead Sciences Inc., is in short supply. Countries are seeking to stockpile it but all are many million doses short of what would be needed to treat a pandemic of any sort of influenza, if there is one.

Last month Roche said Indonesia, Thailand and the Philippines were free to begin making their own versions of the drug because it does not have patent protection in these countries.
'"/>




Related medicine news :

1. FDA Imposes New Restrictions On Roches Accutane
2. Roche offers HIV drug expertise to poor nations
3. Roche Commits More Antiviral Pills To Asia For Bird Flu
4. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
5. Roche Rolls Out Lung Cancer Drug In India
6. New Lung Cancer Drug Launched By Roche Pharmaceutical
7. Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
8. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
9. NICE Gives the Final ‘NO’ to Roche’s Tarcva
10. SARS research confirms link to animals
11. Irritable bowel syndrome associated with food intake, confirms blood test
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... Chesapeake, VA (PRWEB) , ... March 22, 2017 ... ... offering asset protection assistance and financial consultations to families and business owners in ... raise support for the local American Cancer Society Relay For Life event. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... The ... related services to communities across eastern Texas, is announcing a charity drive in ... to hungry children and adults. , Consistently a top-rated nonprofit organization for ...
(Date:3/22/2017)... ... , ... Schneider Insurance and Financial, a southern Montana firm providing asset protection ... is launching a charity event aimed at raising local support for Zoo Montana. , ... and is home to a broad variety of animals from all over the world. ...
(Date:3/22/2017)... ... March 22, 2017 , ... Chris Humphrey Insurance Agency, a North Carolina ... throughout the coastal plains region, is initiating a charity event to raise support for ... first diagnosed with leukemia on a Friday evening in September 2014. At the time, ...
(Date:3/22/2017)... ... March 22, 2017 , ... College basketball surges to its peak during ... recruiting – that is, recruiting people to be foster parents. Through a televised spot, ... are in foster care due to abuse, neglect and other family challenges. People who ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 23, 2017 ... 2021, a latest research report. The global vagus nerve ... shift of surgeons focus toward minimally invasive VNS procedures. ... limited to few developed countries having high standards of ... ...
(Date:3/22/2017)... , 22 de marzo de 2017   ... líder de soluciones de productos y servicios para ... que ha adquirido EPL Archives, Inc., una organización ... clientes en todo el ciclo de vida de ... una muestra de archivo, almacenamiento de documentos y ...
(Date:3/22/2017)... , Mar. 22, 2017 Research and ... Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 10.9% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Medicine Technology: